![Page 1: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/1.jpg)
Minutes of the Brown University Community Council (BUCC) Meeting
Tuesday, November 13, 2018 4:00 – 5:30 p.m.
Members: President Paxson, Provost Locke, Russell Carey, Cass Cliatt, Eric Estes, Kayla Rosen, Matthew Harrison, Alla Hassan, Justin Izzo, Jung-Eun Lee, Evelyn Lincoln, Matthew McGarrell, Claire Heiden, Shanze Tahir, Nathan Blouin, Robert Kashow, Alastair Tulloch, Peter Mattson, Chloe Zimmerman, Heather Cole, Aixa Kidd, Joanne McEvoy, Linda Welsh, Olajumoke Akinsulire, Lauren Allister, Guy Sanchez were in attendance. Erin DeBobes, Sarah Besky, Rachel Cassidy, Shipra Vaishnava, Jee Won Kang, Anuj Krishnamurthy, Rachael Schmidt, Shayna Kessel, Michelle Nuey, and Thanos Chaltas were unable to attend. President Paxson spoke about the campus climate surveys that are being administered and the importance of participating and providing feedback. She highlighted the involvement of graduate students in the review process for the new graduate student grievance procedures that were recently adopted by the faculty. She discussed the Harvard admission case and confirmed Brown’s firm support for the use of holistic admissions in which race is one of many factors considered when deciding whether to offer an applicant admission to Brown. Logan Powell, Dean of Admission, presented admission statistics and trends at Brown. He noted the role of the common application and Brown’s need blind admission policy in the growth of applications over the past several years. Also during this time, Brown’s admit rates have dropped and yields have gained. Mr. Powell attributed much of the 20% increase in the class of 2023 early decision applicant pool over last year to The Brown Promise initiative, which beginning in 2018-19 replaces loans with scholarship funds in all University-packaged undergraduate financial awards. He reported that the number of applicants who indicated an interest in applying for financial aid increased by 11% over last year. Mr. Powell shared a number of recent admission office policy changes including: a doubling of travel grants for low-income students; an automatic waive of application fees for low-income students; an additional ADOCH session; the inclusion of early decision admits in ADOCH; launch of a new website; pay for tour guides and information session student leaders; and formation of a working group on access for first-gen and low-income students. Daniel Behr, Executive Director of the Office of Industry Engagement and Commercial Venturing (IECV), reviewed the mission of IECV: to unleash the impact of Brown's research by encouraging and facilitating the evolution of Brown's discoveries and inventions into know-how, products and services with societal and economic value. He explained that the IECV Office supports the mission through its three programmatic pillars: commercial venturing, industry engagement, and translational development. Through commercial venturing, the Office partners with Brown researchers to determine the market relevance of their discoveries, then forges the best strategy for transitioning from idea to impact. For industry engagement, the Office builds strategic relationships with industry focused on research collaborations aimed at spawning innovations of commercial interest to its company partners. For translational development, it provides and manages translational development capabilities to help solidify proof of technical feasibility and of commercial relevance. Mr. Behr highlighted the Brown Biomedical Innovations to Impact (BBII), a translational commercial development program. The BBII manages an academic accelerator fund dedicated to supporting academic biomedical technologies to become well-defined product opportunities. The next meeting of the Brown University Community Council will be held on Wednesday, March 20 from 4:00 – 5:30 pm in the Stephen Robert ’62 Campus Center, Kasper Multipurpose Room. Respectfully submitted, Catherine Pincince Secretary of the Brown University Community Council
![Page 2: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/2.jpg)
Brown University Community Council Tuesday, November 13, 2018
4:00 – 5:30 pm Stephen Robert ’62 Campus Center, Kasper Multipurpose Room
Agenda
1. Approval of Minutes of October 9, 2018 Meeting
2. Updates from the Office of Admission
Logan Powell
3. Overview of the Office of Industry Engagement & Commercial Venturing Daniel Behr
4. Open Time for University Community Members to Present Broad Campus Issues
to the Council
![Page 3: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/3.jpg)
Brown University Community Council
November 2018
Logan PowellDean of Admission
![Page 4: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/4.jpg)
Applications/Admits/Matrics: Classes of 1973-2022
-
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
1973
1974
1975
1976
1977
1978
1979
198
019
81
198
219
83
198
419
85
198
619
87
198
819
89
199
019
91
199
219
93
199
419
95
199
619
97
199
819
99
200
020
01
200
220
03
200
420
05
200
620
07
200
820
09
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Applications Admits Matrics
Early Decision - 2006
Brown Promise - 2022
Common Application - 2013
Need blind admission policy - 2007
![Page 5: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/5.jpg)
Admit Rates Over Time11%
9% 9%
10%
9% 9%
8%
9%
8%
7%
0%
2%
4%
6%
8%
10%
12%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Ad
mit
Rat
e
Class Year
![Page 6: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/6.jpg)
Yield Over Time (as of May 1)
58.10%58.70%
56.20%55.80%
58.60%
61.20%
53.00%
54.00%
55.00%
56.00%
57.00%
58.00%
59.00%
60.00%
61.00%
62.00%
Class of 2017 Class of 2018 Class of 2019 Class of 2020 Class of 2021 Class of 2022
![Page 7: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/7.jpg)
3,089 3,040 3,030 3,186
3,501
4,196
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
2018 2019 2020 2021 2022 2023
Early Decision Applications: Classes 2018-2023
Class Year
App
. Vol
ume
(+5%)(+10%)
(+20%)
![Page 8: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/8.jpg)
Early Decision Applications by Region: Classes 2018-2023
243 240 229 233208
298
392 408 417443
521
622
355 358379 379
422
514459
513479
525
608
744
0
100
200
300
400
500
600
700
800
2018 2019 2020 2021 2022 2023
App
licat
ion
Vol
ume
Mid West California South International
(+22%)
(+19%)
(+22%)
(+43%)
![Page 9: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/9.jpg)
Early Decision Applications by Financial Aid: Classes 2018-2023
1624 1555 1502
1705
2015
2229
0
500
1000
1500
2000
2500
2018 2019 2020 2021 2022 2023
App
licat
ion
Vol
ume
Financial Aid
(+11%)
![Page 10: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/10.jpg)
Recent Admission Office Policy Changes
Double Travel Grants for Low-Income Students
Two ADOCH programs; invite Early Decision Admits
Automatically Waive Application Fees for Low-Income Students
Creation of a Financial Aid Brochure
New Website v.1.0
Tour Guides and Information Session Student Leaders will be paid – starting Spring 2019
Working Group on Access for First-Gen and Low-Income Students
![Page 11: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/11.jpg)
© 2016 Brown University© 2018 Brown University
![Page 12: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/12.jpg)
OFFICE OF INDUSTRY ENGAGEMENT AND COMMERCIAL VENTURINGUNLEASHING THE IMPACT OF BROWN’S RESEARCH
OVERVIEW FOR BUCC - NOVEMBER 13, 2018Daniel Behr, Executive Director
![Page 13: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/13.jpg)
About Daniel Behr
Industry Engagement& Commercial Venturing
Lab to MarketBench to BedsideIdea to Impact
COMMERCIALIZING EARLY-STAGE INNOVATIONS
STARTUPSVENTURE
INVESTING
UNIVERSITYLAB-TO-MARKET
DEVELOPMENT
• SLIPS Technologies• Rediscovery Life Sciences• Arradiance• Compact Instruments• IN USA
• BridgeGap Ventures• Allied Minds• Seed Partners
• Brown• Harvard• UMass
![Page 14: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/14.jpg)
The Office of Industry Engagement &Commercial Venturing (IECV)
Industry Engagement& Commercial Venturing
Supports the evolution of Brown discoveries, innovations & know-how into products and services with societal and commercial impact
thus helping to fulfill Brown’s IMPACT-driven mission
![Page 15: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/15.jpg)
IndustryPartners
Connecting Brown with the Commercial Ecosystem
VentureInvestors
Entrepreneurs
Brown’sFaculty& StudentBrain-trust
Brown’sDiscoveries,Know-How& Inventions
Industry Engagement& Commercial Venturing
Office ofIndustry Engagement
& Commercial Venturing
![Page 16: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/16.jpg)
The Idea-to-Impact (i2i) Gap
IECV’s Goal: Bridge the Gap
Industry Engagement& Commercial Venturing
![Page 17: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/17.jpg)
The 3 Pillars of the IECV Program
Industry Engagement& Commercial Venturing
Commercial Venturing
Translational Development
Industry Engagement
Supported by a practical IP strategyand a user-friendly transactional approach
![Page 18: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/18.jpg)
IMPACT
Translational Development
(Establish technical & commercial relevance)
Partner with existing company
Create a startup company
Industry Engagement& Commercial Venturing
Why the 3 Pillars?
IDEA
![Page 19: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/19.jpg)
Commercial venturingQ1: Does the innovation enable a solution to an unmet need?
Validatethe Unmet Need
• What problem needs to be solved?
• Why does solving it matter?
• How big is the need and the potential opportunity?
Define the Solution and its Value Proposition
• What product or service will be offered as a solution?
• Who will buy it and what is the buying decision process?
• Why will it be readily adopted in the marketplace?
Create a SustainableCommercial Model
• How will the solution be deployed and scaled?
• What are its meaningful advantages (including IP) vs. alternatives?
• What resources and funding are required for success?
Adapted from Brown’s Nelson Center for EntrepreneurshipIndustry Engagement
& Commercial Venturing
Bonus: This process enhances the ENTREPRENEURIAL ACUMEN of Brown’s researchers
![Page 20: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/20.jpg)
Industry EngagementStrategic partnerships that go beyond one-off projects
Industry Engagement& Commercial Venturing
Focus on industry partner’sunmet innovation needs
Engage in research collaborationsto spawn ideas & innovations
• Taps broadly into Brown’s “brain-trust” (researchers & students)• Reaches beyond what’s on the table or already published• Connects companies to students for recruiting• Companies can leverage other assets at Brown
• Nelson Center for Entrepreneurship• School of Professional Studies
Innovations enable real-worldproducts for industry partner
IMPACT!
![Page 21: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/21.jpg)
The Translational Development Gap
Industry Engagement& Commercial Venturing
Ready to cross the gap and be taken up by industry or funded
as startups
Translational Development Target:
Commercially promising innovations stuck
in the “valley of death” gap
Not commercially viable or relevant to
marketplace
Innovations from academic
and clinical research
institutions
U.S. research universities such as Brown continue to lead the world in generating innovations. Many of these are commercially viable but stuck in the “valley of death” gap.
![Page 22: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/22.jpg)
Translational Development at Brown
Industry Engagement& Commercial Venturing
Brown Biomedical Innovations Inc (BBII):• $8M “product accelerator” fund focused on biomedical / human health
innovations
• Soft-launch in early 2017 - 2 projects underway
• Fully operational launch underway in Fall 2018
• Jointly operated by IECV and Brown’s Warren Alpert Medical School
Future: create similar program for physical and computational sciences?
![Page 23: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/23.jpg)
Examples of impact from Brown’s research
Industry Engagement& Commercial Venturing
• Medley Genomics - precision oncology startup• Techstyles - smart building material• Optimization algorithm (logistics)• Antibody for lung cancer• Cellintec - immune system status
More Mature• BodyLabs - 3D body model startup - (acquired for $50M by Amazon Q3’17)• Rudolf - technology to measure semiconductor thin films• Tivorsan - DMD therapeutic (close to IND) • Spectra - technology for bank note authentication • Audax Medical - orthopedic nanomaterials for bone and soft tissue regeneration
In the Pipeline• Pediatric malaria vaccine• Oral delivery of protein drugs• Scalable tissue fabrication• Small molecule for idiopathic pulmonary fibrosis• Baby Cry - diagnostic for NAS
![Page 24: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/24.jpg)
U.S. research universities
Industry Engagement& Commercial Venturing
$800M-$1B ~$500M $150-$200M
![Page 25: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/25.jpg)
U.S. research universities
Industry Engagement& Commercial Venturing
190 $65B
62% Federal
7% Industry
P.S.: Brown is only at 1.9%
![Page 26: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/26.jpg)
U.S. research universities: innovation
Industry Engagement& Commercial Venturing
16,000 patent applications
annually
Streptomycin antibiotic (Rutgers)
Laser cataract surgery (UCLA)
Search algorithm(Stanford)
Sports drink(U of Florida)
![Page 27: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/27.jpg)
U.S. research universities: economic impact
Industry Engagement& Commercial Venturing
$2.5BLicensing Income 20,000
Active Licenses
($125K/license)
$125BAnnual commercial
sales based on university innovations
![Page 28: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/28.jpg)
The rare, unpredictable, highly desirable unicorns
Industry Engagement& Commercial Venturing
>$1B $336M(sale of stock)
~$750M ~$250M
![Page 29: Minutes of the Brown University Community Council (BUCC ......Biomedical Innovations to Impact (BBII) , a translational commercial development program. The BBII manages an academic](https://reader034.vdocuments.net/reader034/viewer/2022042305/5ed0846831579e17926e6223/html5/thumbnails/29.jpg)
Brown: Innovation Built on STEM + Liberal Arts
Industry Engagement& Commercial Venturing
Innovation for theHuman Context